CEO: | Carolyn Cross |
CFO and COO: | Michael S. Behlke |
Chairman: | Jean Charest |
Chief Technology Officer: | Nicolas Loebel |
Independent Non-Executive Director: | Simon Sinclair |
Independent Non-Executive Director: | Junaid Bajwa |
Interim CFO: | Kwong Choo |
Senior Independent Non-Executive Director: | Jean Duvall |
Non-Executive Dir: | Craig Tooman |
Address: | 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6 |
Phone: | +1 604 669 0555 |
Website: | https://ondinebio.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | CA68234M2058 |
Currency | UK Pounds |
Share Price | 8.37p |
Change Today | -0.13p |
% Change | -1.53 % |
52 Week High | 13.30 |
52 Week Low | 5.63 |
Volume | 555 |
Shares Issued | 443.23m |
Market Cap | £37.10m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
08:30 | 555 @ 9.00p |
Chair | Jean Charest |
CEO | Carolyn Cross |
You are here: research